K, B., A, A., M, M., S, M., F, Y., V, B., . . . O, R. (2022). Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19. Frontiers in pediatrics, 10, 893045. https://doi.org/10.3389/fped.2022.893045
Chicago Style (17th ed.) CitationK, Bline, et al. "Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19." Frontiers in Pediatrics 10 (2022): 893045. https://doi.org/10.3389/fped.2022.893045.
MLA (9th ed.) CitationK, Bline, et al. "Myeloid-Derived Suppressor Cells and Clinical Outcomes in Children With COVID-19." Frontiers in Pediatrics, vol. 10, 2022, p. 893045, https://doi.org/10.3389/fped.2022.893045.
Warning: These citations may not always be 100% accurate.